# A Study to Investigate the Effect of Probiotics (L. Reuteri ATCC PTA 5289 and L. Reuteri DSM 17938) on Symptoms of Viral Upper Respiratory Tract Infections in Children

> **NCT06205966** · NA · UNKNOWN · sponsor: **Milosevits Gergely** · enrollment: 142 (estimated)

## Conditions studied

- Virus Diseases in Children

## Interventions

- **DIETARY_SUPPLEMENT:** BioGaia Pharax (L. reuteri PTA 5289 and DSM 17938)
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT06205966
- **Lead sponsor:** Milosevits Gergely
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-12-21
- **Primary completion:** 2025-11-30
- **Final completion:** 2025-11-30
- **Target enrollment:** 142 (ESTIMATED)
- **Last updated:** 2024-01-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06205966

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06205966, "A Study to Investigate the Effect of Probiotics (L. Reuteri ATCC PTA 5289 and L. Reuteri DSM 17938) on Symptoms of Viral Upper Respiratory Tract Infections in Children". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06205966. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*